The page is the record's research on the issuer — no analyst, no rating, no view.

# PILA PHARMA AB (First North Sweden: SE0015988274) — research page

As of 2026-11-06 · se-cm-kg · record version 1

## Identity and listing

The issuer is PILA PHARMA AB, listed on First North Sweden under ticker SE0015988274. Its ISIN is SE0015988274 and its LEI is 6488Z7WG18Q0ZN0V0262. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 35 filings in the twelve months to 2026-11-06, across 28 filing days. The median gap between filing days is 11 days. The latest filing is dated 2026-11-02, is of type Investor News, and is 4 days before the record date. The median gap between filing days for First North Sweden is 11 days across 325 issuers, the median filings count is 21, and the median latency is 7 days. The sector median is not on the record.

## Auditor

The auditor of record is not on the record, and its location is not on the record. Auditor changes are not on the record, because the market's record does not carry a lifecycle type map for this register.

## Events and halts

The record does not carry listing, delisting, name change, domicile change or segment move events, because the market's register has no lifecycle type map. The halt flag is listed, not halted.

## Orderability

The orderability outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's investor-relations page names 8 research houses: Redeye Equity Research, AktieInfo Equity Research, AG Equity Research, Carlsquare Equity Research, Redeye Equity Research Sweden, AktieInfo Equity Research Denmark, AG Equity Research Sweden and Carlsquare Equity Research Sweden.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.

## Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://firds.esma.europa.eu/firds/ (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.se-cm-kg.ai/events/SSME/SE0015988274 (the disclosure lines)
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- https://pilapharma.com/analyst-coverage/ (coverage)
- https://mcp.se-cm-kg.ai/record/SSME/SE0015988274 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/se/SSME/SE0015988274 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp